In Myasthenia Gravis, Antibodies Pass Open-Label Tests
PHOENIX — Open-label extension studies of two neonatal Fc receptor–blocking antibodies showed good safety and efficacy in patients with myasthenia gravis (MG). ...
PHOENIX — Open-label extension studies of two neonatal Fc receptor–blocking antibodies showed good safety and efficacy in patients with myasthenia gravis (MG). ...
Artificial intelligence (AI) models are typically a year out of date and have this "charming problem of hallucinating made-up data ...
(Reuters) - The U.S. Food and Drug Administration (FDA) on Tuesday published letters warning two online vendors to stop selling ...
An experimental stem cell therapy for the treatment of mild to moderate amyotrophic lateral sclerosis (ALS) received a resounding rejection ...
The US Food and Drug Administration (FDA) today approved the JAK inhibitor momelotinib (Ojjaara) for myelofibrosis patients with anemia, according ...
The US Food and Drug Administration (FDA) has granted accelerated approval to the off-the-shelf biologic agent elranatamab (Elrexfio) for the ...
The US Food and Drug Administration (FDA) has approved niraparib and abiraterone acetate (Akeega, Janssen Pharmaceuticals) to treat BRCA-positive, metastatic ...
The US Food and Drug Administration (FDA) today cleared an artificial intelligence (AI)-assisted colonoscopy device called the MAGENTIQ-COLO, according to ...
A US Food and Drug Administration (FDA) investigation of injection-site necrosis in some people who received the 23-valent pneumococcal vaccine ...
The US Food and Drug Administration has cleared the Tandem Mobi insulin pump for people with diabetes aged 6 years ...
© Pharma News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Pharma News Hubb All rights reserved.